✦ LIBER ✦

PIN55 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Positive Chronic Hepatitis B in Poland

✍ Scribed by M. Jakubczyk; J. Pawęska; M. Niewada; H. Berak; M. Szkultecka-Dębek; M. Russel-Szymczyk

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN67 Cost-Effectiveness Analysis of Peg

✍ M. Jakubczyk; J. Pawèska; M. Niewada; H. Berak; M. Szkultecka-dèbek; M. Russel-s 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

HBeAg-Negative Chronic Hepatitis B: Cost

✍ David L. Veenstra; Sean D. Sullivan; Ming-Yang Lai; Chuan-Mo Lee; Chia-Ming Tsai 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

PIN9 A COST UTILITY ANALYSIS OF PEGINTER

✍ NR Latimer; GJ Lewis 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

712 EFFICACY AND SAFETY OF PEGINTERFERON

✍ D.-Z. Xu; Y. Xie; L. Wei; X.-Y. Chen; M.-B. Wan; Y.-M. Wang; L. Wang; J. Wei; J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

492 HBeAg and HBV DNA kinetics in HBeAg

✍ M.W Fried; Y.E. Liaw; K.X. Luo; G.K.K. Lau; T. Piratvisuth; G. Cooksley; P. Marc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Pharmacokinetics of peginterferon ALFA-2

✍ R. Bruno; P. Sacchi; V. Ciappina; E. Maffezzini; S.F.A. Patruno; C. Zocchetti; G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 319 KB